Syndax Pharmaceuticals Inc (SNDX)
Financing Cash Flow
$252.77M
Quarterly · Period ending: · USD
SNDX Financing Cash Flow
Latest reported$252.77Mperiod ending
Latest reported$252.77Mperiod ending
SNDX Quarterly Cash from Financing ($1.17K → $252.77M)
Quarterly financing cash flow
High-resolution chart · PNG
SNDX financing cash flow history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Financing Cash Flow (USD) |
|---|---|
| 252,770,000 | |
| 7,918,000 | |
| 5,917,000 | |
| 6,278,000 | |
| 551,000 | |
| 930,000 | |
| 347,425,000 | |
| 3,098,000 | |
| 676,000 | |
| 2,168,000 | |
| 258,483,000 | |
| 1,851,000 | |
| 1,324,000 | |
| 2,474,000 | |
| 163,502,000 | |
| -13,525,000 | |
| 21,720,000 | |
| 557,000 | |
| 109,779,000 | |
| 1,705,000 | |
| 6,020,000 | |
| 960,000 | |
| 138,658,000 | |
| 1,767,000 | |
| 109,001,000 | |
| 54,998,000 | |
| 58,000 | |
| 80,000 | |
| 6,000 | |
| 28,426,000 | |
| 6,145,000 | |
| 9,462,000 | |
| 89,000 | |
| 33,000 | |
| 25,614,000 | |
| 1,004,000 | |
| 48,987,000 | |
| 117,000 | |
| 176,000 | |
| 1,710,000 | |
| -1,232,000 | |
| 53,548,000 | |
| -9,182,000 | |
| 60,060,000 | |
| 18,677,000 | |
| 7,712,000 | |
| 3,995,000 | |
| 9,511,000 | |
| -892,000 | |
| -204,000 | |
| 11,875,000 | |
| 6,475,000 | |
| 1,005,000 | |
| 1,534,000 | |
| 1,173 |